12:00 AM
 | 
Feb 22, 2016
 |  BC Week In Review  |  Clinical News  |  Regulatory

BD FACSPresto Near-Patient CD4 Counter system regulatory update

FDA granted 510(k) clearance to Becton Dickinson’s BD FACSPresto system and BD FACSPresto CD4/Hb Cartridge to measure absolute and percentage results...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >